Het Jeroen Bosch ziekenhuis is een algemeen ziekenhuis in 's-Hertogenbosch. Deze locatie aan de Henri Dunantlaan werd geopend in 2011. Er zijn daarnaast nog nevenvestigingen in Boxtel, Drunen, Rosmalen en Zaltbommel.

During the past decade, Jeroen Bosch Ziekenhuis conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 24 clinical trials were completed, i.e. on average, 22% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 13 clinical trials were completed. i.e. 22.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jeroen Bosch Ziekenhuis" #1 sponsor was "Radboud University Medical Center" with 32 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 16 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 9 trials sponsored, "The Netherlands Cancer Institute" with 9 trials sponsored and "Hoffmann-La Roche" with 9 trials sponsored. Other sponsors include 107 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jeroen Bosch Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 19 trials as a collaborator, "Jeroen Bosch Ziekenhuis" with 11 trials as a collaborator, "Dutch Cancer Society" with 10 trials as a collaborator, "Borstkanker Onderzoek Groep" with 6 trials as a collaborator and "Bayer" with 5 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 169 trials.

According to Clinical.Site data, the most researched conditions in "Jeroen Bosch Ziekenhuis" are "Breast Cancer" (8 trials), "Colorectal Cancer" (7 trials), "Bladder Cancer" (6 trials), "Alzheimer Disease" (5 trials) and "Breast Neoplasms" (5 trials). Many other conditions were trialed in "Jeroen Bosch Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Jeroen Bosch Ziekenhuis" are "Drug" (112 trials), "Other" (39 trials), "Procedure" (26 trials), "Biological" (14 trials) and "Behavioral" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Docetaxel" (7 trials), "Pemetrexed" (7 trials), "Carboplatin" (5 trials) and "cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Jeroen Bosch Ziekenhuis" are 159 trials for "All" genders, 17 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Jeroen Bosch Ziekenhuis". undefined are not yet recruiting, 42 are recruiting, 25 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 70 completed trials in Jeroen Bosch Ziekenhuis, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Jeroen Bosch Ziekenhuis, 2 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 37 trials that are defined as “Not Applicable".